Zhejiang Jiaao Enprotech Stock (603822.SH): The holding company has obtained a license for the export of bio-aviation fuel.
ST Jiaao (603822.SH) announced that its controlling subsidiary Lianyungang Jiaao New Energy Co., Ltd. recently received a reply from the Office of the Ministry of Commerce of the People's Republic of China regarding the application for the 2026 bioaviation fuel export permit for "white-listed" enterprises. The main content is as follows: After assessment, Lianyungang Jiaao is capable of producing 372,400 tons of bioaviation fuel at full capacity in 2026 and is allowed to apply for an export permit within this production capacity for the year 2026.
Announcement from Zhejiang Jiaao Enprotech Stock (603822.SH): The company's controlling subsidiary, Jiangsu Lianyungang Port Jiao Xin Energy Co., Ltd., has recently received a reply from the office of the Ministry of Commerce of the People's Republic of China regarding the application for the issuance of a 2026 biojet fuel export permit for "white list" enterprises. The main content is as follows: after verification, Jiangsu Lianyungang Port Jiao Xin can produce 372,400 tons of biojet fuel at full capacity in 2026, and is allowed to apply for an export permit within the above production capacity range for 2026.
Related Articles
New stock outlook | Accounts receivable accounts for more than 60% of revenue, how can Youlesai tell a good story of circular packaging?
"Zootopia 2" breaks box office records and tops the animated film box office champion of Walt Disney Company(DIS.US).
The new national medical insurance list will be implemented starting today, benefiting patients with three innovative drugs from SKB BIO-B (06990).
New stock outlook | Accounts receivable accounts for more than 60% of revenue, how can Youlesai tell a good story of circular packaging?
"Zootopia 2" breaks box office records and tops the animated film box office champion of Walt Disney Company(DIS.US).
The new national medical insurance list will be implemented starting today, benefiting patients with three innovative drugs from SKB BIO-B (06990).
